Ann: Suspension from Official Quotation, page-175

First 175 Last

Share
Profile

Follow
hottuna

3,053 Posts.

2

19/05/17

19:00

Post #: 24803910
Share

Originally posted by milesy ↑

Share price falls often become self-fulfilling.

As you would be aware HT, institutions can have very strict investment parameters that require them to sell on certain TA or FA triggers.

Just because an institution is selling does not necessarily mean it is because they believe something is inherently wrong with the company.

Apart from the shorters report, there has been no other mainstream broker downgrades.

Even the credit rating downgrades have come about because of the prospect of lower revenue. Even this becomes self-fulfilling in that as confidence is lost, buyers of both the end product and the MIS's will hold off making their purchase.

Only time will tell if the shorters were right to begin with, but certainly the damage inflicted may lead them to be right in the future.

Let's see if management can sway opinion, produce contracts and build the type of company touted by them. Their task is certainly that much more difficult now.

On another note, I've looked, but cannot find any mention of you closing your short position until after the TH was called?

Milesy

Expand

Totally incorrect. Canaccord, the house broker suspended coverage citing a lack of transparency, Argonaut downgraded them, UBS have put them 'under review' and the debt has been downgraded twice by both Moody's and S&P.

You appear to be basing your views off totally false premises.

QIN Price at posting: 29.5¢ Sentiment: Sell Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

MM1

Midas logs 17 spodumene pegmatite targets over 4km at Aylmer Project in Canada but drills while off

AZY

Antipa's Minyari Dome reveals gold up to 24g/t through drilling at key prospect

PYC

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

There are more pages in this discussion • 128 more messages in this thread...

First 175 Last

Add QIN (ASX) to my watchlist

Ann: Suspension from Official Quotation, page-175

Top Stories

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Midas logs 17 spodumene pegmatite targets over 4km at Aylmer Project in Canada but drills while off

Antipa's Minyari Dome reveals gold up to 24g/t through drilling at key prospect

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

Featured News